NASDAQ : ACOG
Alpha Cognition Inc. — Key statistics
Healthcare · Biotechnology · Canada
Last price 8.74 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 190.34M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 181.63M |
| Enterprise Value | 140.24M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 21.78M |
| Shares Outstanding | 21.78M |
| Shares Change (YoY) | +66.85% |
| Shares Change (QoQ) | -0.69% |
| Owned by Insiders (%) | 3.97% |
| Owned by Institutions (%) | 14.14% |
| Float | 11.02M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.04 |
| Forward PS | 5.00 |
| PB Ratio | 3.59 |
| P/TBV Ratio | 3.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 9.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 9.03 |
| Quick Ratio | 7.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -49.53% |
| Return on Assets (ROA) | -30.39% |
| Return on Invested Capital (ROIC) | -39.27% |
| Return on Capital Employed (ROCE) | -45.88% |
| Weighted Average Cost of Capital (WACC) | 16.50% |
| Revenue Per Employee | $214,940 |
| Profits Per Employee | -$295,962 |
| Employee Count | 71 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 0.40 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.23 |
| 52-Week Price Change | +34.73% |
| 50-Day Moving Average | 8.91 |
| 200-Day Moving Average | 7.16 |
| Relative Strength Index (RSI) | 42.95 |
| Average Volume (20 Days) | 95,533 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 352,521 |
| Short Previous Month | 323,405 |
| Short % of Shares Out | 1.62% |
| Short % of Float | 3.20% |
| Short Ratio (days to cover) | 3.27 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 15.26M |
| Gross Profit | 13.79M |
| Operating Income | -26.66M |
| Pretax Income | -21.01M |
| Net Income | -21.01M |
| EBITDA | -26.49M |
| EBIT | -26.66M |
| Loss Per Share | -$1.05 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 41.38M |
| Total Debt | n/a |
| Net Cash | 41.38M |
| Net Cash Per Share | $1.90 |
| Equity (Book Value) | 52.96M |
| Book Value Per Share | 2.43 |
| Working Capital | 51.51M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -30.85M |
| Capital Expenditures | -321,796 |
| Depreciation & Amortization | 173,032 |
| Net Borrowing | n/a |
| Free Cash Flow | -31.18M |
| FCF Per Share | -$1.43 |
Margins
| Measure | Value |
|---|
| Gross Margin | 90.37% |
| Operating Margin | -174.70% |
| Pretax Margin | -137.70% |
| Profit Margin | -137.70% |
| EBITDA Margin | -173.57% |
| EBIT Margin | -174.70% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -66.85% |
| Shareholder Yield | -66.85% |
| Earnings Yield | -12.59% |
| FCF Yield | -16.96% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $18.00 |
| Price Target Difference | 115.83% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 101.69% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Nov 5, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.42 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |